In addition, a dramatic case was reported, in which a patient with metastatic colon carcinoma was treated with anti-ERBB2-CAR-Ts and subsequently died of respiratory failure, which was attributed to “on-target/off-tumor” toxicities in the lung (6). The gene discussed is ERBB2; the disease is respiratory failure.